Comparative Analysis of PLTR and TLRY: Trends, Prices, and Volatility
Swing trader: Top High-Volatility Stocks (TA) 29.85% for PLTR vs Swing trader: Top High-Volatility Stocks v.2 (TA) 31.46% for TLRY
Stock Performance Overview: PLTR vs TLRY
Palantir Technologies (PLTR), a notable player in the packaged software industry, and Tilray Inc. (TLRY), a leading name in the pharmaceutical sector, are often compared in the stock market, especially by swing traders, for their high volatility.
In the past week, PLTR experienced a price decline of 7.98%, while TLRY showed a slightly better performance with a lesser price drop of 3.66%.
As the overall packaged software industry suffered a small weekly decline of 1.07%, PLTR's performance was notably lower. On the other hand, TLRY fared better than its industry's average weekly price growth, which was -0.39%.
Monthly and Quarterly Price Growth Trends
Looking at the longer-term performance, the packaged software industry, where PLTR operates, enjoyed a monthly price growth of 3.70% and an impressive quarterly growth of 23.99%. Unfortunately, the story for PLTR wasn't as rosy.
On the flip side, the Pharmaceuticals: Another industry, where TLRY belongs, experienced a monthly price contraction of 1.96% and meager quarterly growth of 0.15%. In comparison, TLRY's week-on-week performance was notably better than the industry trend.
Upcoming Earnings Reports
Investors and traders should be aware of the upcoming earnings reports for both PLTR and TLRY. PLTR is expected to release its earnings report earlier than TLRY, on August 9, 2023, while TLRY will announce its earnings later on October 6, 2023. The earnings report often incites significant price movements, making these dates crucial for swing traders.
Technical Analysis (TA) and Fundamental Analysis (FA) Scores
PLTR’s TA score leans bearish, with 2 bullish and 6 bearish indicators. TLRY, on the other hand, appears more balanced with a TA score of 5 bullish and 5 bearish indicators.
Both PLTR and TLRY present a concerning FA score, with no green and 5 red indicators each. This fundamental analysis suggests that investors may need to exercise caution and thoroughly evaluate their investment strategies with these stocks.
PLTR and TLRY, both representing top high-volatility stocks, exhibit stark differences in their recent price performance and industry growth trends. As the companies approach their earnings reports and continue to demonstrate high volatility, swing traders are advised to monitor these stocks closely and make informed decisions based on comprehensive analysis. The bearish FA scores for both stocks serve as a reminder for potential investors to tread with caution.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
The RSI Indicator for TLRY moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 47 similar instances when the indicator left oversold territory. In 39 of the 47 cases the stock moved higher. This puts the odds of a move higher at 83%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in 166 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLRY as a result. In 70 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for TLRY turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 37 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
TLRY moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TLRY crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TLRY entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.368) is normal, around the industry mean (43.873). P/E Ratio (8.518) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis
Industry PharmaceuticalsGeneric